Technology · Synthetic biology investment
Investment in synthetic biology in Norway stands at 200 M $ in 2026. Despite a strong scientific base in molecular biology, the commercialization of projects in this field is still in its infancy. Norwegian startups like Norilia and Arctic Bioscience primarily attract funding through government grants rather than venture capital. The country ranks 11 out of 197 in investment volume.
Data for 2026 · unit: $
Position
#11 / 197
Norway world ranking
Country position on the scale from last to first place for this indicator.
NO
#11
#197#1
Trend
Change over time
Change in indicator over the available period.
1 M
2010
5 M
2020
180 M
2025
200 M
2026
Values — $
Comparison
Top countries by Synthetic biology investment
Where Norway stands in the world ranking.
1
CNChina
6 B
2
RURussia
2.5 B
2
USUSA
2.5 B
4
GBUnited Kingdom
800 M
5
CACanada
700 M
6
DKDenmark
350 M
7
NZNew Zealand
300 M
7
AUAustralia
300 M
Full world rankingarrow_forward
People also search for
Other pages of the reference by this indicator.
Frequently asked questions
Synthetic biology investment in Norway — how much?
Based on 2026 data — 200 M $. This is rank #11 out of 197 countries.
What is Norway's rank by Synthetic biology investment?
Norway ranks #11 out of 197 countries in the world ranking by «Synthetic biology investment».
How has Synthetic biology investment changed in Norway?
Over the available period the indicator changed from 1 M to 200 M $.